Polycystic Ovary Syndrome: Contemporary Viewpoint

The document from 2010 discusses Polycystic Ovary Syndrome (PCOS), a complex condition characterized by hyperandrogenism and chronic anovulation, with diagnostic criteria that were broadened by the 2003 Rotterdam criteria. Prevalence rates of PCOS vary, with figures such as 4.5% to 11.2% in Alabama, 9% in Greece, and 6.5% in Spain reported. Common associated conditions include obesity, dyslipidemia, and insulin resistance, with obesity affecting 30% to 75% of women with PCOS. The exact cause of PCOS is unknown, but androgen excess and insulin resistance are considered key factors in its pathogenesis. Lifestyle changes, particularly weight loss, are fundamental in managing PCOS, alongside treatments to address symptoms and reduce health risks. The document also notes the presence of markers for endothelial dysfunction and chronic inflammation in PCOS, which may have implications for long-term health. The document emphasizes that PCOS is a significant metabolic disorder with ongoing research into its health impacts and underlying causes, and that its definition and classification are still evolving.